Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
30/04/2025
ASMPT reported first-quarter revenue of 3.12 billion Hong Kong dollars, slightly below the estimated 3.2 billion Hong Kong dollars; first-quarter net profit was 83.6 million Hong Kong dollars.
Latest
2 m ago
According to AI Express on April 29, Pacific Securities issued a research report, giving Anhui Xinchuan Media (601801.SH) a "buy" rating. The main reasons for the rating include: 1) the decrease in performance in 2024 due to the impact of income tax, with the elimination of the impact in Q1 2025 bringing about a year-on-year high increase; 2) the integration of digital intelligence empowering business development and continuous layout in smart education; 3) cash dividends and share repurchases enhance investment value. (Daily Economic News)
3 m ago
Every Economy AI Express, Pacific Securities issued a research report on April 30th, giving Bio-Kangt biomaterial Co., Ltd. (688526.SH) a buy rating. The main reasons for the rating include: 1) Industry competition intensification in 2024 leads to pressure on product gross margins; 2) In 2025, new major products are expected to achieve sales breakthroughs. (Daily Economic News)
3 m ago
PACIFIC released a research report on April 30th, giving a buy rating to Yuandong Biotechnology (688513.SH). The main reasons for the rating include: 1) steady growth of main products and significant contribution from new products; 2) actively promoting mergers and collaborations to accelerate the development of innovative drugs. (Daily Economic News)
3 m ago
The education sector continues to strengthen, with Dou Shen Education rising by over 4%, followed by Zhonggong Education, Kaiwen Education, Quantong Education, Huatu Shanding, Xueda Education, and Kede Education.
3 m ago
Chongqing: Various measures are taken to promote residents' income increase, and continue to promote listed companies' cash dividends and share repurchases.
See all latest